Showing results (1-10 of 639) with videos related to
Sort By:
Pageof 64
Science (New York, N.Y.)|November 4, 1988
Cellular and molecular mechanisms of drug dependenceG F Koob, F E BloomFederation Proceedings|January 1, 1985
Corticotropin-releasing factor and behaviorG F Koob, F E BloomNeurochemistry International|April 1, 1997
Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic responseJ Raber, G F Koob, F E BloomScience (New York, N.Y.)|July 17, 1981
Response artifact in the measurement of neuroleptic-induced anhedoniaA Ettenberg, G F Koob, F E BloomThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic responseJ Raber, G F Koob, F E BloomPsychopharmacology|January 1, 1989
Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawalG F Koob, T L Wall, F E BloomPsychopharmacology|January 1, 1985
Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the ratF J Vaccarino, F E Bloom, G F KoobPsychopharmacology|January 1, 1990
Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergideF Weiss, M Mitchiner, F E Bloom, et al.Neuroscience and Biobehavioral Reviews|January 1, 1989
Opponent process theory of motivation: neurobiological evidence from studies of opiate dependenceG F Koob, L Stinus, M Le Moal, et al.Regulatory Peptides|June 1, 1985
Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressureC Lebrun, M Le Moal, G F Koob, et al.Pageof 64